Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-0141-2020

Drug recall · October 23, 2019

Fentanyl Citrate USP recall

Why: CGMP Deviations: Received notice from supplier that there is potential glass contamination.

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Fentanyl Citrate USP, Active Pharmaceutical Ingredient, Spectrum Chemical MFG. CORP., Gardena, CA 90248 NDC 49452-0032-06

Lots / codes

Lot # 1HE0899, 1IB0005, Exp 02/28/2023

Quantity
29.1 grams
Company
Spectrum Laboratory Products, Gardena, CA
Distribution
Product was distributed to compounding pharmacies and labs in CA, CO, MD, SC.
Initiated
September 12, 2019 · Voluntary: Firm initiated
Classified
October 15, 2019
Reported
October 23, 2019
Ended
November 10, 2020
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Fentanyl

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.